| 1 |
Identification of patients at high risk of secondary extramedullary multiple myeloma development |
|
| | Martin Stork, Sabina Sevcikova, Jiri Minarik, Petra Krhovska, Jakub Radocha, Lenka Pospisilova, Lucie Brozova, Jiri Jarkovsky, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Tomas Jelinek, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour | | | British Journal of Haematology. 2021; 1833(1): 231 | | | [Pubmed] [Google Scholar] | | | 2 |
Lenalidomide/plerixafor |
|
| | | | | Reactions Weekly. 2020; 1833(1): 231 | | | [Pubmed] [Google Scholar] | |
|
